ZAP isoforms regulate unfolded protein response and epithelial- mesenchymal transition.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
02 08 2022
Historique:
entrez: 26 7 2022
pubmed: 27 7 2022
medline: 29 7 2022
Statut: ppublish

Résumé

Human ZAP inhibits many viruses, including HIV and coronaviruses, by binding to viral RNAs to promote their degradation and/or translation suppression. However, the regulatory role of ZAP in host mRNAs is largely unknown. Two major alternatively spliced ZAP isoforms, the constitutively expressed ZAPL and the infection-inducible ZAPS, play overlapping yet different antiviral and other roles that need further characterization. We found that the splicing factors hnRNPA1/A2, PTBP1/2, and U1-snRNP inhibit ZAPS production and demonstrated the feasibility to modulate the ZAPL/S balance by splice-switching antisense oligonucleotides in human cells. Transcriptomic analysis of ZAP-isoform-specific knockout cells revealed uncharacterized host mRNAs targeted by ZAPL/S with broad cellular functions such as unfolded protein response (UPR), epithelial-mesenchymal transition (EMT), and innate immunity. We established that endogenous ZAPL and ZAPS localize to membrane compartments and cytosol, respectively, and that the differential localization correlates with their target-RNA specificity. We showed that the ZAP isoforms regulated different UPR branches under resting and stress conditions and affected cell viability during ER stress. We also provided evidence for a different function of the ZAP isoforms in EMT-related cell migration, with effects that are cell-type dependent. Overall, this study demonstrates that the competition between splicing and IPA is a potential target for the modulation of the ZAPL/S balance, and reports new cellular transcripts and processes regulated by the ZAP isoforms.

Identifiants

pubmed: 35881805
doi: 10.1073/pnas.2121453119
pmc: PMC9351355
doi:

Substances chimiques

Heterogeneous Nuclear Ribonucleoprotein A1 0
Heterogeneous-Nuclear Ribonucleoproteins 0
PTBP1 protein, human 0
Protein Isoforms 0
RNA, Messenger 0
RNA, Viral 0
RNA-Binding Proteins 0
Ribonucleoproteins, Small Nuclear 0
SNRNP35 protein, human 0
ZC3HAV1 protein, human 0
hnRNPA1 protein, human 0
Polypyrimidine Tract-Binding Protein 139076-35-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2121453119

Références

Nature. 2011 Apr 28;472(7344):481-5
pubmed: 21478870
J Virol. 2003 Nov;77(21):11555-62
pubmed: 14557641
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15834-9
pubmed: 21876179
Nat Struct Mol Biol. 2012 Mar 11;19(4):430-5
pubmed: 22407013
Mol Cell. 2011 Sep 16;43(6):927-39
pubmed: 21925381
Nat Commun. 2017 Nov 21;8(1):1638
pubmed: 29158484
Science. 2002 Sep 6;297(5587):1703-6
pubmed: 12215647
Nat Rev Mol Cell Biol. 2020 Aug;21(8):421-438
pubmed: 32457508
Cell Physiol Biochem. 2018;49(3):1007-1018
pubmed: 30196292
Cell. 2019 Jun 13;177(7):1797-1813.e18
pubmed: 31104839
Nat Commun. 2014 Nov 10;5:5362
pubmed: 25382312
J Virol. 2004 Dec;78(23):12781-7
pubmed: 15542630
Nucleic Acids Res. 2002 Jan 1;30(1):207-10
pubmed: 11752295
Nat Immunol. 2011 Jan;12(1):37-44
pubmed: 21102435
PLoS Genet. 2008 Jan;4(1):e21
pubmed: 18225958
PLoS One. 2014 Dec 29;9(12):e114931
pubmed: 25545659
J Gen Virol. 2014 Apr;95(Pt 4):816-822
pubmed: 24457973
Nat Commun. 2021 Dec 10;12(1):7193
pubmed: 34893599
Mol Biol Cell. 2007 Dec;18(12):5048-59
pubmed: 17898077
J Biol Chem. 2010 Feb 26;285(9):6080-90
pubmed: 20048147
Nat Immunol. 2019 Dec;20(12):1610-1620
pubmed: 31740798
Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11085-90
pubmed: 23776219
PLoS Pathog. 2020 Sep 4;16(9):e1008844
pubmed: 32886716
Aging (Albany NY). 2021 Jul 28;13(14):18482-18497
pubmed: 34319912
Trends Mol Med. 2015 Jun;21(6):373-84
pubmed: 25851173
mBio. 2021 May 4;12(3):
pubmed: 33947766
Dev Cell. 2018 Jun 18;45(6):681-695.e4
pubmed: 29920274
J Clin Invest. 2009 Jun;119(6):1429-37
pubmed: 19487819
J Virol. 2019 Aug 28;93(18):
pubmed: 31118263
Nucleic Acids Res. 2019 Jan 8;47(D1):D203-D211
pubmed: 30239819
Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12379-84
pubmed: 23836649
Mol Cell. 2021 Jul 1;81(13):2838-2850.e6
pubmed: 33989516
Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30687-30698
pubmed: 33184176
PLoS Genet. 2015 May 22;11(5):e1005252
pubmed: 26001115
Science. 2014 Nov 7;346(6210):1257521
pubmed: 25378630
J Virol. 2007 Mar;81(5):2391-400
pubmed: 17182693
Dev Cell. 2020 Nov 9;55(3):298-313.e10
pubmed: 33171110
Gene. 2017 Aug 20;625:21-30
pubmed: 28476687
PLoS Pathog. 2018 Jul 17;14(7):e1007166
pubmed: 30016363
Nat Struct Mol Biol. 2009 Feb;16(2):176-82
pubmed: 19169258
Int J Mol Med. 2016 Jun;37(6):1521-7
pubmed: 27121032
Mol Cell. 2011 May 20;42(4):489-99
pubmed: 21596313

Auteurs

Phuong Thao Ly (PT)

School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore.

Shaohai Xu (S)

School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore.

Melissa Wirawan (M)

Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 636921, Singapore.

Dahai Luo (D)

School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore.
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 636921, Singapore.

Xavier Roca (X)

School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH